Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tharimmune ( (THAR) ) has issued an announcement.
On August 26, 2025, Tharimmune, Inc. entered into a securities purchase agreement for a registered direct offering of $5.35 million in securities, consisting of 1,188,888 shares of Common Stock at $4.50 per share. The offering, under a shelf registration statement effective since March 24, 2023, is expected to close on August 27, 2025, with President Street Global, LLC and RF Lafferty & Co., Inc. acting as exclusive co-placement agents.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 9,160,340
Technical Sentiment Signal: Buy
Current Market Cap: $35.74M
See more data about THAR stock on TipRanks’ Stock Analysis page.